Barinthus Biotherapeutics plc - American Depositary Shares — 현금 흐름 (NASDAQ:BRNS)

Financials

영업활동으로 인한 현금 -32.58 M-14.43 M-50.92 M-28.94 M-47.98 M -36.44 M 투자 활동으로 인한 현금 -12.91 M-5.75 M-5.41 M-892 K416 K 476 K 재무활동으로 인한 현금 222.74 M325 K1.87 M2.16 M2 000 0 잉여 현금 흐름 -32.58 M-14.43 M-50.92 M-28.94 M-48.02 M -36.48 M

Barinthus Biotherapeutics plc - American Depositary Shares

Barinthus Biotherapeutics plc is a biotechnology company developing immunotherapies for infectious diseases, cancer and autoimmune diseases such as hepatitis B, HPV and prostate cancer. Formerly known as Vaccitech plc, in November 2023 the company announced that it had renamed itself to Barinthus Biotherapeutics plc. As of 2024, the company employs more than 100 people.

BRNS

Financials

Barinthus Biotherapeutics plc - American Depositary Shares

뉴스

Barinthus Biotherapeutics PLC Sponsored ADR (BRNS) Upgraded to Buy: What Does It Mean for the Stock?

바린투스 바이오, 셀리악 치료제 임상 초기 데이터 긍정적

Barinthus Bio reports positive initial data from celiac therapy trial

H.C. 웨인라이트, 바린투스 바이오테라퓨틱스 ’매수’ 등급 재확인

Barinthus Biotherapeutics stock rating reiterated at Buy by H.C. Wainwright

Barinthus Bio and Clywedog to merge in all-stock deal

Barinthus Biotherapeutics’ CEO Bill Enright to Present at the Investor Summit Virtual on June 10, 2025